Trade Summary

3 days ago, Bonstein Sara, serving as Chief Financial Officer at INSMED Inc (INSM), sold 2,404 shares at $102.27 per share, for a total transaction value of $245,857.08. Following this transaction, Bonstein Sara now holds 69,082 shares of INSM.

This sale represents a 3.36% decrease in Bonstein Sara's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, June 3, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 4:14 PM ET, 2 days after the trade was made.

INSMED Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.